Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity
Trends in Immunology · 2023-04 · 44 (4) · 266-275
DOI: 10.1016/j.it.2023.02.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2023-04. Verfasst von Richard M Ransohoff. Beteiligte Einrichtung: Third Rock Ventures, Boston, MA, USA; Abata Therapeutics, 100 Forge Road, Suite 200, Boston, MA 02472, USA. Electronic address: rransohoff@abatatx.co…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Rock Ventures, Boston, MA, USA; Abata Therapeutics, 100 Forge Road, Suite 200, Boston, MA 02472, USA. Electronic address: rransohoff@abatatx.com.
Förderung
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Ransohoff, R. M. (2023). Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity. Trends in Immunology, 44(4), 266-275. https://doi.org/10.1016/j.it.2023.02.002
Vancouver
Ransohoff RM. Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity. Trends in Immunology. 2023;44(4):266-275. doi:10.1016/j.it.2023.02.002
BibTeX
@article{Ransohoff2023,
author = {Ransohoff, Richard M},
title = {Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity},
journal = {Trends in Immunology},
year = {2023},
volume = {44},
number = {4},
pages = {266--275},
doi = {10.1016/j.it.2023.02.002}
}
EUVIMED